the cabinet
Drugs
8,127 products tracked
Phase 2
efpegerglucagon
efpegerglucagon [INN]
Hyperinsulinemia
Hanmi Pharmaceuticals Co Ltd
0 catalysts
Phase 3efruxifermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Akero Therapeutics Inc
0 catalysts
Phase 3efsudenermin alfa
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
EspeRare Foundation
0 catalysts
Phase 3